Effect of blonanserin on cognitive impairment in schizophrenic patient-non-blinded, randomized, comparative study with olanzapine

Trial Profile

Effect of blonanserin on cognitive impairment in schizophrenic patient-non-blinded, randomized, comparative study with olanzapine

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2013

At a glance

  • Drugs Blonanserin (Primary) ; Olanzapine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Apr 2013 Planned end date changed from 1 May 2015 to 31 Dec 2015 as reported by University Hospital Medical Information Network - Japan record.
    • 03 Apr 2013 Planned initiation date changed from 1 Aug 2012 to 1 Jun 2013 as reported by University Hospital Medical Information Network - Japan record.
    • 07 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top